Home > Healthcare > Medical Devices > Diagnostic Devices > Bronchoscopy Market

Bronchoscopy Market Share

Report ID: GMI5249
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Bronchoscopy Market Share

The bronchoscopy industry is consolidated, with key players such as Boston Scientific, and few others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in August 2021, Boston Scientific Corporation received the U.S. FDA approval for its single-use bronchoscope EXALT MODEL B. designed to be used in bedside procedures within the operating room (OR) and intensive care unit (ICU). Therefore, introduction of such products helps the company in strengthening its product portfolio coupled with sustaining its market position.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

External pacemaker industry size was USD 1.2 billion in 2022 and is estimated to exceed USD 1.9 billion by the end of 2032 due to the rising prevalence of cardiovascular diseases and the increasing advancements in product technology.

External pacemaker industry size from the dual-chamber technology was USD 731 million in 2022 and is expected to exhibit robust growth through 2032 driven by the surging need to enhance blood flow and cardiac output, with the potential to improve oxygenation in the body's tissues and organs.

External pacemaker industry size from the hospitals end-use segment is projected to reach more than USD 1.1 billion by the end of 2032 owing to surging need for rapid and reliable outcomes ?

U.S. external pacemaker industry size is expected to exceed USD 633.7 million by 2032 owing to the increasing demand for cardiovascular devices and the surging number of hospital admissions in the country.